Latest News
- BREXIT: What does it mean for the Life Sciences? 1-Jun-2018
- New Committee Members 26-Feb-2018
- Exploratory Medicines Development: Innovation And Risk Management, London, May 2017 – one week away 10-May-2017
- Abstract and Bursary deadlines 31-Jan-2017: Big Data & the Development of New Medicines 30-Jan-2017
- Big Data & the Development of New Medicines 8-Dec-2016
Archives
- June 2018 (1)
- February 2018 (1)
- May 2017 (1)
- January 2017 (1)
- December 2016 (2)
- November 2016 (2)
- October 2016 (2)
- May 2016 (6)
- April 2016 (2)
- March 2016 (1)
- February 2016 (2)
- January 2016 (2)
- December 2015 (2)
- November 2015 (9)
- October 2015 (1)
- August 2015 (1)
- July 2015 (1)
- June 2015 (2)
- March 2015 (1)
- February 2015 (1)
- September 2014 (1)
- July 2014 (1)
- January 2014 (3)
- November 2013 (1)
- July 2013 (1)
- June 2013 (2)
- April 2013 (2)
- February 2013 (1)
- January 2013 (1)
- December 2012 (1)
- November 2012 (3)
- October 2012 (2)
- June 2012 (1)
- May 2012 (1)
- March 2012 (3)
- December 2011 (1)
- November 2011 (3)
- July 2011 (1)
- March 2011 (1)
Monthly Archives: December 2015
Survey Results for AHPPI’s Annual Meeting
Steffan Stringer, published 23-Dec-2015. Correspondence steffan.stringer@alwynconsulting.co.uk. ©2015 Steffan Stringer, Alwyn Consulting, www.alwynconsulting.co.uk This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original … Continue reading
Comments Off on Survey Results for AHPPI’s Annual Meeting
Sponsors have up to 30 months after the end of a trial to publish results of Category 1 trials under EU CTR
On 05 October 2015, the EMA signed the Appendix, on disclosure rules, to the “Functional specifications for the EU portal and EU database to be audited – EMA/42176/2014”. In this document, the EMA introduces a new categorisation of clinical trials. Trials … Continue reading
Comments Off on Sponsors have up to 30 months after the end of a trial to publish results of Category 1 trials under EU CTR